Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,282 public trials 1,199 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

NCT06769126

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +12 more
Locations
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Eisenhower Medical Center Rancho Mirage, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 148 locations
View Trial Details
Recruiting

Study of Trilaciclib and Lurbinectidin

NCT05578326

Conditions
Agranulocytosis, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
Locations
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT05837767

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

NCT06538038

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mercy Clinic Fort Smith Communities Fort Smith, Arkansas, United States
  • Mercy Research Fort Smith, Arkansas, United States
  • Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 146 locations
View Trial Details
Recruiting

Durvalumab as Consolidation for Patients LS-SCLC

NCT07055581

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou, Henan, China
  • Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details

Related conditions